UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X]               Quarterly  report  pursuant  to  Section  13 or  15(d)  of the
                  Securities  Exchange  Act of  1934  For the  quarterly  period
                  ended: September 30, 1999

[  ]              Transition  report  pursuant to Section 13 or 15(d) of the
                  Securities  Exchange  Act of 1934 For the transition period
                  from _______ to _________

                                          Commission file number: 000-25557

                             AGRI BIO-SCIENCES, INC.
        (Exact name of small business issuer as specified in its charter)

                  Delaware                             76-0481583
       (State or other jurisdiction of                I.R.S. Employer
       incorporation or organization                   Identification No.)

       5211 Court of York, Houston, Texas                77069
      (Address of principal executive officer)          (Zip Code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No ___

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE
PRECEDING FIVE YEARS

Check whether the  registrant  filed all  documents  and reports  required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities under a plan confirmed by a court Yes ___ No ___

APPLICABLE ONLY TO CORPORATE ISSUERS

         The number of shares of common  stock,  $0.01 par value,  outstanding
 as September  30, 1999:  11,050,000
shares

Transitional Small Business Disclosure Format (check one):   Yes ___   No  X


<PAGE>


                             AGRI BIO-SCIENCES, INC.
                         PERIOD ENDED SEPTEMBER 30, 1999

                                      INDEX
<TABLE>
<CAPTION>

PART I.  FINANCIAL INFORMATION                                                                                 Page

         Item 1.  Financial Statements

         Condensed financial statements of Agri Bio-Sciences, Inc.:

<S>                                                                                                             <C>
                  Balance sheet as of September 30, 1999                                                          3

                  Income  statements  for the three and nine months  ended
                   September 30, 1999, three months and nine months
                   ended September 30, 1998 and period from May 30, 1995 (Date
                   of Inception) to September 30, 1999                                                            4

                  Statements of cash flows for the nine months  ended  September
                    30,  1999,  the nine  months  ended  September  30, 1998 and
                    period from May 30, 1995 (Date of Inception) to September
                    30, 1999                                                                                      5

                  Notes to financial statements                                                                   6

         Item 2.  Plan of Operations                                                                              7

PART II. OTHER INFORMATION

         Item 2.  Changes in Securities and Use of Proceeds                                                      10

         Item 6.  Exhibits and Reports on Form 8-K                                                               10

                  (a)      Exhibits

SIGNATURE                                                                                                        11
</TABLE>










                                        2

<PAGE>


PART I. FINANCIAL INFORMATION

Item 1.   Financial Statements

                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                                  Balance Sheet
                               September 30, 1999
<TABLE>


ASSETS
<S>                                                                                                       <C>
     Cash$                                                                                               2,694

     Fertilizer plant and equipment, net                                                               164,386
                                                                                                       -------


         TOTAL ASSETS                                                                                 $167,080




LIABILITIES
     Accounts payable                                                                                 $ 26,926
     Accrued expenses                                                                                    9,311
     Due to current stockholders                                                                       118,000
     Due to former stockholder                                                                         100,000
                                                                                                      --------


         TOTAL LIABILITIES                                                                             254,237


STOCKHOLDERS' EQUITY
     Common stock, $.001 par value, 20,000,000
         shares authorized, 10,900,000 issued
         and outstanding                                                                                10,900
     Paid in capital                                                                                   582,250
     Deficit accumulated during the development stage                                                 (680,307)
                                                                                                      --------

     TOTAL STOCKHOLDERS' EQUITY (DEFICIT)                                                             ( 87,157)
                                                                                                      --------

     TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                       $167,080
                                                                                                      ========


</TABLE>







                                        3

<PAGE>


                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                             Statements of Expenses
                   9 Months Ended September 30, 1999 and 1998
                  and the period from May 30, 1995 (Inception)
                           Through September 30, 1999
<TABLE>
<CAPTION>


                                                     - - 1999       - - 1999          - - 1998         - - 1998        May 30,1995
                                                     3 Months       9 months          3 Months         9 Months         (Inception)
                                                        Ended          Ended             Ended            Ended        to Sep. 30,
                                                      Sep. 30        Sep. 30           Sep. 30           Sep 30               1999


EXPENSES
<S>                                                    <C>               <C>            <C>                 <C>             <C>
     Fees paid for services
       by stockholders                                                                                                   $ 168,400
     Other administrative                            $ 32,142       $ 75,809         $  13,251        $  73,574            364,317
     Inventory writedown                                                               100,000          100,000            100,000
     Interest                                                                                             2,710             38,090
     Depreciation                                       1,250          3,750             1,250            3,750              9,500
                                                     --------       --------         ---------        ---------          ---------

         Net (loss)                                  $(33,392)      $(79,559)        $(114,501)       $(180,034)         $(680,307)
                                                     ========       ========         =========        =========          =========


(Loss) per common share                                $(.003)        $(.007)           $(.010)          $(.020)
Weighted average
     shares outstanding                            10,900,000     10,900,000        10,900,000       10,777,778



</TABLE>


















                                        4

<PAGE>


                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)
                            Statements of Cash Flows
                   9 Months Ended September 30, 1999 and 1998
                  and the period from May 30, 1995 (Inception)
                           Through September 30, 1999

<TABLE>
<CAPTION>

                                                                                                         Inception
                                                                                                           Through
                                                                           1999             1998              1999
                                                                       ---------       ----------        ----------
CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                    <C>                <C>               <C>
     Net (loss)                                                        $(79,559)       $(180,034)        $(680,307)
     Adjustments to reconcile net income
         to net cash provided by
         operating activities
       Depreciation                                                       3,750            3,750             9,500
       Common stock issued for services                                                                     67,650
       Writedown of inventory value                                                      100,000           100,000
       Contribution of imputed interest                                                                     30,000
     Changes in:
       Other current assets                                                                7,500
       Accounts payable                                                  19,014            4,927            26,926
       Accrued expenses                                                   1,500         (  1,200)            9,310
                                                                       --------        ---------         ---------
       NET CASH USED BY
                  OPERATING ACTIVITIES                                  (55,295)        ( 65,057)         (436,920)
                                                                       --------        ---------         ---------

CASH FLOWS FROM INVESTING ACTIVITIES
     Plant site construction and equipment
         purchases                                                                                        ( 73,886)
                                                                                                         ---------
       NET CASH USED FOR
                  INVESTING ACTIVITIES                                                                    ( 73,866)
                                                                   -------------    -------------        ---------

CASH FLOWS FROM FINANCING ACTIVITIES
     Sales of common stock for cash                                                      137,500           895,500
     Purchase of stock from a former
         shareholder                                                                                      (500,000)
     Advances by shareholders                                            46,000           52,000           118,000
                                                                        -------        ---------         ---------
       NET CASH PROVIDED BY
                  FINANCING ACTIVITIES                                   46,000           61,290           513,500
                                                                       --------        ---------         ---------

NET INCREASE (DECREASE) IN CASH                                         ( 9,295)        (  3,737)            2,694

CASH   - Beginning of period                                             11,989            7,597
         - End of period                                               $  2,694        $   3,830         $   2,694
                                                                       ========        =========         =========

SUPPLEMENTAL DISCLOSURES
     Non-cash investing and financing activities:
       Contribution of plant site at inception                                                            $100,000
       Purchase of bagged fertilizer for
         note payable                                                                                      100,000

</TABLE>

                                        5

<PAGE>

                         NOTES TO FINANCIAL STATEMENTS
                             AGRI BIO-SCIENCES, INC.
                          (A Development Stage Company)



NOTE 1 - BASIS OF PRESENTATION

The accompanying  unaudited interim financial  statements of Agri  Bio-Sciences,
Inc.  have been  prepared  in  accordance  with  generally  accepted  accounting
principles  and  should  be read  in  conjunction  with  the  audited  financial
statements  and notes thereto  contained in the  Company's  latest Annual Report
filed  with  the  SEC  on  Form  10-KSB.  In  the  opinion  of  management,  all
adjustments, consisting of normal recurring
 adjustments,  necessary for a fair  presentation of financial  position and the
results of operations  for the interim  periods  presented  have been  reflected
herein.  The  results of  operations  for interim  periods  are not  necessarily
indicative  of the  results  to be  expected  for the  full  year.  Notes to the
financial   statements  which  would  substantially   duplicate  the  disclosure
contained in the audited  financial  statements for the most recent fiscal year,
1998, as reported in the 10-KSB, have been omitted.





























                                                         6



<PAGE>


Item 2.      PLAN OF OPERATION

         Agri Bio-Sciences,  Inc., a Delaware corporation (the "Company"),  is a
developmental  stage company formed for the production of a fertilizer  known as
"Micro Min." It has not yet commenced full-scale  production  activities and has
not generated any revenues from operations. While there can be no assurance that
the Company will be able to generate  meaningful  revenues or achieve profitable
operations,  the Company has received its first purchase order for Micro Min and
expects to receive additional purchase orders in the near future.

         On November 3, 1999,  100,000 registered shares of the Company's Common
Stock,  par value $.001 per share  ("Common  Stock"),  were  distributed  to the
stockholders  of GS  Financial  Services,  Inc.,  a  Delaware  corporation  ("GS
Financial"),  thus establishing a public float for the Common Stock. The Company
is currently  seeking to procure an initial market maker for the Common Stock so
that public trading in the Common Stock may commence in the near future.

EXCLUSIVE SALE AND PURCHASE ARRANGEMENT:

         The Company was formed  solely for the purpose of  manufacturing  Micro
Min and does not  intend  to  engage  in the sale and  marketing  of Micro  Min.
Instead, Global Farm Sciences, Inc., a Texas corporation ("Global"),  was formed
in  December  1997 by Lester  Stephens,  M. Manny  Kalish and  Patrick N. Morgan
(founders and board members of the Company) for the purpose of selling Micro Min
to  foreign  entities.  On August  27,  1998,  the  Company  signed a  five-year
exclusive product sales agreement with Global. This Agreement requires Global to
purchase  2,000  metric  tons of Micro  Min  during  the year  1999 and 2000 and
thereafter  purchase 3,000 metric tons of Micro Min during each succeeding year.
Global  must pay  $620.00  per  metric  ton in United  States  dollars,  FOB the
Company's plant facility in Bay Springs,  Mississippi.  Global must remit 50% of
the  purchase  price with each  purchase  order for Micro Min  forwarded  to the
Company.  (This  initial  amount  provides  the Company with  adequate  funds to
produce  one metric ton of product  and thereby  provides  the Company  with the
necessary funds to keep the plant in operation).  Thereafter,  Global must remit
the remaining 50% payment of its purchase  order to the Company within ninety 90
days of their receipt of the product FOB the plant.  The Global agreement may be
terminated prior to its five-year term upon the occurrence of certain  customary
termination events, such as breach of contract or bankruptcy.

         During the quarter  ended  September  30, 1999,  the Company and Global
realized that the success of Global's business  activities in Mexico was limited
due to Global's  status as a foreign  corporation in that country.  Accordingly,
with the knowledge and consent of the Company, Global has been employing Ciences
Agro  Ambientales,  S.A.  de C.V.  ("CIAGAM")  to  undertake  the  sales-related
activities that Global was originally to undertake.  CIAGAM is indirectly  owned
by certain  members of the  Company's  Board of  Directors,  and is a registered
Mexican  corporation  fully authorized under Mexican corporate law. Global's use
of CIAGAM for sales-related activities is expected for the
                                                         7
<PAGE>

foreseeable future.  While there has been no formal assignment of Global's
rights and obligations under its exclusive  product sales agreement with the
Company,  such an assignment has been discussed and may occur in the future.

STATUS OF SALES EFFORTS:

         For some time, Global has been holding  discussions with  FERTILIZANTES
NACIONALES,  S.A. de C.V.  ("FERTINAL")  regarding a possible  agreement whereby
FERTINAL would be the exclusive reseller of Micro Min in Mexico.  FERTINAL is an
established  fertilizer sales organization in Mexico which reports that it has a
35% market share of fertilizer sales in Mexico and it operates approximately 260
warehouses located  throughout Mexico capable of holding  fertilizer  inventory.
While discussions with FERTINAL continue,  no definitive agreement with FERTINAL
has been reached.

         In addition,  for some time,  Global has been holding  discussions with
The  College of  Agricultural  Engineers  (the  "College")  regarding a possible
arrangement  whereby  members of the College  would attempt to sell Micro Min to
farmers in  Mexico.  The  College  is an  association  of  graduates  of various
agricultural  colleges  in  Mexico  and  estimates  that  it  has  about  15,000
agricultural  engineer members  nationwide.  While discussions with the Colleges
continue, no definitive agreement with the College has been reached.

         Because  of the  delay  in  establishing  a  formal  relationship  with
FERTINAL,  the College or another  large sales  force,  CIAGAM  itself is making
sales calls on critical governmental and quasi-governmental  agencies as well as
private  businesses.  In this  connection,  CIAGAM received an initial  purchase
order for 290 metric tons of Micro Min from Asesoria Integral Agrupecuaria, S.A.
de C.V. ("ASIA"),  a fertilizer  distributor in Mexico. The Micro Min ordered is
to be delivered as soon as  practical.  One hundred  twenty (120) metric tons of
Micro Min is already located in warehouses in Mexico. Another 120 metric tons of
Micro  Min  is  located  at  the  Company's   plant  facility  in  Bay  Springs,
Mississippi,  bagged and ready to be shipped.  The Company is now in the process
of  filling  ASIA's  order,  and the  Company  expects to  reactivate  its plant
facility in Bay Springs,  Mississippi  shortly after the 1999 holiday  season in
order to produce the remaining  Micro Min needed to fill the order.  As a result
of the ASIA purchase order,  the Company expects to realize  revenues in January
2000.  Management  believes that CIAGAM will receive additional  purchase orders
from ASIA in the future, although there can be no assurance in this regard.

BANK FINANCING SALES:

         CIAGAM  has  recently  established  a  relationship  with the  Banco de
Mexico,  the national bank of Mexico. The Banco de Mexico has indicated a desire
to establish a credit line  sufficient for Mexican  farmers to purchase  certain
items of agriculture  necessary for growing crops. Although CIAGAM and the Banco
de Mexico have not agreed upon  definitive  terms nor  entered  into  definitive
agreements regarding the line of credit,
                                                         8
current  discussions  are revolving  around  certain terms.  First,  the line of
credit is expected to have a total amount ranging from $425,000 to $1.2 million.
This amount of funding is expected to service adequately an eight-state targeted
area in Mexico.  In addition,  amounts advanced on the line of credit to farmers
will be due and payable approximately 90 days after the advance. Moreover, as is
customary,  the line of credit would  require the farmers to place their land in
trust as collateral against the amounts advanced. Finally, CIAGAM is expected to
be required to guarantee a  comparatively  small  portion of each advance on the
line of credit.  Despite the current  status of the  negotiations  regarding the
line of credit, there can be no assurance that CIAGAM will successfully conclude
such negotiations and establish a line of credit with the Banco de Mexico or any
other lender.

LABORATORY OPERATION:

         Intertek Testing Service ("ITS") is an ISO 9002 Certified  company with
offices in 102 countries of the world. It has eleven laboratories in Mexico. ITS
will be using the Company's laboratory computer copyrighted software and testing
protocols  to do the soil,  water and plant  testing for all  farmer/clients  of
CIAGAM.  Assisting them in this service is Global's vice president of laboratory
technology, Robert A. Kalish. The ITS laboratory in Mexico City will receive the
sample and  process it using the  Company's  computer  copyrighted  software  to
complete an analytical report for the farmer which depicts the present condition
of the farmer's soil.  This report also  recommends the exact  fertilizers to be
used both in kind and amounts on a per acre basis.  Management  believes  that a
service like this has never before available to the farmers of Mexico.  The soil
analytical report will be reduced to computer language and forwarded by MODEM to
a computer in the sales office servicing the farmer/client.  Global reports that
it has sufficient funds in its budget to install  computers in each of the sales
offices in those  initial areas being  targeted for Micro Min sales.  A computer
server is presently installed in the ITS offices in Mexico City.

CORPORATE FUTURE GOALS:

         The Company  (through  CAIGAM)  intends to continue to pursue  sales of
Micro Min in Mexico and possibly  complete broad product sales  agreements  with
FERTINAL,  the College or some other firm or  organization  having a large sales
force. In addition,  the Company would like to begin exploring  (through Global)
the possibility of establishing a sales program in Columbia. The Company already
has a product  license for Micro Min in that country as well as  associates  and
relationships with important agricultural institutions and organizations. Global
is currently  planning on a possible  visit to Columbia in the first  quarter of
year 2000 to explore  more  closely  the  possibility  of  establishing  a sales
program in Columbia.

CAPITAL REQUIREMENTS, RESEARCH AND DEVELOPMENT AND EQUIPMENT EXPENDITURES:

         The Company does not believe that it will need any financing over the
next 12
                                                         9
<PAGE>

months.  Management  believes  that  the  Company  will be able to  finance  its
operations  through  its  receipt of down  payments  in the amount of 50% of the
purchase price of each purchase  order issued by Global.  Such down payments are
expected to cover all direct costs of producing the related product. The Company
has only minimal  overhead,  which has thus far been  financed  through  amounts
advanced by M. Manny Kalish, a director of the Company. Mr. Kalish has indicated
that he intends to continue to provide limited financing of overhead,  but he is
under no legal obligation to do so and may cease at any time.

         Moreover,  the Company does not intend to conduct any further  research
and  development  over the next 12 months.  However,  if CIAGAM  meets its sales
expectations,  the  Company  expects  to add  (during  the  next  12  months)  a
California  Pellet Mill pelletizer and sufficient  additional  employees to meet
the demand for additional production.

PART II. OTHER INFORMATION

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS

         During the quarter ended September 30, 1999, the Company did not effect
any sale of any equity  securities  not  registered  under the Securities Act of
1933.

         On April 22, 1999,  the Company's  Registration  Statement on Form SB-2
(Commission File No. 333-51977) was declared effective by the U.S Securities and
Exchange  Commission.  This Registration  Statement registered 100,000 shares of
the Common Stock held by GS Financial.  Pursuant to a written  agreement between
the Company and GS Financial,  these  100,000  shares of Common Stock were to be
distributed to the  stockholders of GS Financial.  The distribution and offering
of these  shares were  completed  on November 3, 1999.  The Company  received no
proceeds from the  distribution.  There was no change in the approximate  actual
expenses incurred by the Company in connection with the distribution  registered
under the Registration Statement from those reflected in the Company's Quarterly
Report on Form 10-QSB for the quarter ended June 30, 1999.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

                  (a) The  following  exhibits  are filed  with  this  Quarterly
Report or are incorporated herein by reference:

                  Exhibit
                  Number                    Description

                   27                       Financial Data Schedule



                                                        10

<PAGE>

                  (b)      Reports on Form 8-K

                           None


                                    SIGNATURE

         In accordance with the requirements of the Exchange Act, the Registrant
has duly  caused  this  Report to be signed  on its  behalf by the  undersigned,
thereunto duly authorized.

                                       AGRI BIO-SCIENCES, INC.
                                      (Registrant)


                                       By: /s/Lester H. Stephens
                                       Lester H. Stephens,
                                       President
                                       (Principal Executive
                                       Officer, Principal
                                       Financial Officer and
                                       Principal Accounting Officer)


Dated: November 15, 1999











                                                        11